ArticleJournal of clinical medicine2024

PR Interval as a Novel Therapeutic Target of Ivabradine Therapy-Prognostic Impact of Ivabradine-Induced PR Prolongation in Heart Failure Patients.

Riona Yamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.